Abstract
Isatin and its derivatives have been widely studied due to their biological activities. Recently there has been a renewed interest in the synthesis of new derivatives by use of organocatalysts. This review deals with this area.
Keywords: Aldol, Asymmetric Catalysis, Friedel-Crafts, Henry, Isatin, Morita-Baylis-Hillman, Organocatalysis.
Current Organic Chemistry
Title:Enantioselective Organocatalytic Reactions with Isatin
Volume: 17 Issue: 18
Author(s): MariFe Flores, Javier Pena, Pilar García-García, Narciso M. Garrido and David Diez
Affiliation:
Keywords: Aldol, Asymmetric Catalysis, Friedel-Crafts, Henry, Isatin, Morita-Baylis-Hillman, Organocatalysis.
Abstract: Isatin and its derivatives have been widely studied due to their biological activities. Recently there has been a renewed interest in the synthesis of new derivatives by use of organocatalysts. This review deals with this area.
Export Options
About this article
Cite this article as:
Flores MariFe, Pena Javier, García-García Pilar, Garrido M. Narciso and Diez David, Enantioselective Organocatalytic Reactions with Isatin, Current Organic Chemistry 2013; 17 (18) . https://dx.doi.org/10.2174/13852728113179990092
DOI https://dx.doi.org/10.2174/13852728113179990092 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
CD44 and EpCAM: Cancer-Initiating Cell Markers
Current Molecular Medicine Attacking c-Myc: Targeted and Combined Therapies for Cancer
Current Pharmaceutical Design Anti-VEGF Mediated Immunomodulatory Role of Phytochemicals: Scientific Exposition for Plausible HCC Treatment
Current Drug Targets Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease
Current Alzheimer Research Study of HIV Resistance Mutations Against Antiretrovirals using Bioinformatics Tools
Current HIV Research From Na+/K+-ATPase and Cardiac Glycosides to Cytotoxicity and Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Design of New Drug Molecules to be Used in Reversing Multidrug Resistance in Cancer Cells
Current Cancer Drug Targets Potential Use of Polymeric Nanoparticles for Drug Delivery Across the Blood-Brain Barrier
Current Medicinal Chemistry Non-Camptothecin DNA Topoisomerase I Inhibitors in Cancer Therapy
Current Topics in Medicinal Chemistry Notch-Associated MicroRNAs in Cancer
Current Drug Targets Organ Preservation by the Association of Chemotherapy and Radiotherapy in Invasive Bladder Cancer
Current Drug Therapy Hsp90 Inhibitor Geldanamycin and Its Derivatives as Novel Cancer Chemotherapeutic Agents
Current Pharmaceutical Design Molecular Imaging of Therapeutic Potential of Reporter Probes
Current Drug Targets Role of Cytokines in Regulating Feeding Behaviour
Current Drug Targets Novel Pentablock Copolymer Based Nanoparticles Containing Pazopanib: A Potential Therapy for Ocular Neovascularization
Recent Patents on Nanomedicine Meet Our Editorial Board Member
Current Drug Therapy Persistent GP130/STAT3 Signaling Contributes to the Resistance of Doxorubicin, Cisplatin, and MEK Inhibitor in Human Rhabdomyosarcoma Cells
Current Cancer Drug Targets Novel Drug-Induced Pulmonary Complications in Cancer Patients You Can Save Life!
Current Respiratory Medicine Reviews Old Tyrosine Kinase Inhibitors and Newcomers in Gastrointestinal Cancer Treatment
Current Cancer Drug Targets Cancer Proteomics: New Horizons and Insights into Therapeutic Applications
Current Proteomics